Study suggests women may be undertreated for obstructive sleep apnea

November 25, 2019

Boston, MA -- Obstructive sleep apnea (OSA) has been considered a predominantly male disease. While more women have been diagnosed with OSA in recent years, the numbers remain disproportionate, with 3-to-5 times more men than women receiving an OSA diagnosis. Investigators from Brigham and Women's Hospital and Yale School of Medicine set out to understand this disparity and its causes. They found that a high proportion of women experienced sleep apnea during dream sleep, which is associated with adverse outcomes including cardiovascular disease. Their findings have implications for the screening, diagnosis and treatment of OSA among women and men and are published in the journal SLEEP.

"Over the years, I've felt strongly that sleep apnea may be an exemplar of a chronic disease that may manifest differently in men and women, from how it presents to its underlying physiology, with implications for how it should be treated," said senior author Susan Redline, MD, MPH, a senior physician in the Division of Sleep and Circadian Disorders in the Departments of Medicine and Neurology at the Brigham. "Here, we begin to drill down to understand how sleep apnea may differ and how common scoring approaches may underestimate sleep apnea in women."

To conduct their study, the investigators analyzed participants in the Multi-Ethnic Study of Atherosclerosis (MESA). Between 2010 and 2013, the team analyzed data from 2,057 MESA participants who underwent a comprehensive sleep study. The mean age of the study participants was 68.

Usually, home-based sleep studies only measure breathing activity, not brain activity and other criteria that can be measured in a sleep lab setting. But for this study, many parameters were measured, including brain activity and body movement.

The team compared a range of summary measures of sleep apnea severity based on the apnea-hyponea index (AHI), the number of breathing pauses per hour of sleep. An AHI greater than 15 is generally considered to indicate moderate to severe sleep apnea and is associated with increased risk of developing hypertension and mortality. The investigators calculated AHI numerous ways, some of which were more sensitive to capturing changes in breathing patterns during REM sleep (dream sleep) and non-REM sleep (other stages of sleep). The team extracted detailed measures from the overnight sleep study to also estimate some of the mechanisms that may cause sleep apnea, including measures of the collapsibility of the airway, the sensitivity of breathing patterns to changes in oxygen and changes in how quickly individuals woke up at night.

The team found that during non-REM sleep, twice as many men as women had an AHI score greater than 15. However, during REM sleep, the prevalence was the same in men and women. Among the study population, almost 60 percent of men and women met diagnostic criteria for moderately severe sleep apnea. The authors note that there is mounting evidence of an association between sleep apnea during REM sleep and adverse cardiovascular outcomes. The study also found that the physiological mechanisms that influence sleep apnea differ in men and women: women had lower loop gain (lower sensitivity to changes in ventilation), less airway collapsibility, and lower arousal threshold (more easily wake up after an apnea) in non-REM sleep. These specific aspects of sleep apnea are thought to be targets for new treatments for sleep apnea.

"We are more and more appreciating that sleep apnea is a heterogeneous disease," said corresponding author Christine Won, MD, MSc, the director of the Women's Sleep Health program at Yale School of Medicine. "It's important to understand how it affects men and women differently. Understanding sex-specific mechanisms allows us to target therapy and is expected to lead to better outcomes."

Medicare currently requires an oxygen desaturation level of 4 percent along with apnea events in order to consider someone to have OSA and receive coverage for treatment. Redline and colleagues compared this definition to other definitions in which the desaturation requirement was not as strict and took into consideration mini-awakenings -- events that are not measured in most at-home sleep studies. The team found OSA rates that were almost double in women when these definitions that counted events that resulted in milder desaturation or awakenings compared to events that were only counted when larger amount of desaturation occurred.

"This suggests that women may be preferentially underdiagnosed when we use the Medicare definition of sleep apnea," said Redline. "Women who have been evaluated using only home-based sleep studies should continue to speak to their doctor if they have not been diagnosed with sleep apnea but continue having symptoms."
-end-
This research was supported by the National Institutes of Health (grants R35HL135818, R01HL098433), the National Heart, Lung, and Blood Institute (contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169), and the National Center for Advancing Translational Sciences (grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420). Redline received grant and consulting support from Jazz Pharmaceuticals. Won reports consulting and personal fees from Jazz Pharmaceuticals and EBSCO Health Industries. A co-author serves as consultant for Somnifix; a co-author reports employment at Philips Respironics, and consulting or personal fees from Animed and Night Balance; a co-author reports personal fees from Nox, Bayer, Somnifix, Apnimed, Galvani, Cambridge Sound.

Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit brighamandwomens.org.

Brigham and Women's Hospital

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.